Gene and Cellular Immunotherapy for Cancer /
Clinical and preclinical exploration of gene and cellular immunotherapy have seen rapid growth and interest with the development and approval of five Chimeric Antigen Receptor T-cell (CAR-T) products for lymphoma and myeloma and one Bispecific T-Cell Engager (BiTE) for acute lymphoblastic leukemia (...
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Cham :
Springer International Publishing : Imprint: Humana,
2022.
|
| Edition: | 1st ed. 2022. |
| Series: | Cancer Drug Discovery and Development,
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Internet
Connect to the full text of this electronic bookAvailable Online
| Call Number: |
R850.A1-854QH315-320 |
|
|---|---|---|
| Call Number | Status | Get It |
| R850.A1-854QH315-320 | Available | |